Updated:
Keles
KELES is a venture capital firm investing in European digital health and techbio companies, with a focus on R&D, diagnostics, and patient care.
Keles
KELES is a venture capital firm investing in European digital health and techbio companies, with a focus on R&D, diagnostics, and patient care. It makes growth-stage investments in companies with demonstrated profitability at a scaling inflection point, with tickets of €8m–€30m and a fund target size of €250m. The firm aims to accelerate digital health growth across Europe and has bases in Paris, London, Brussels and Luxembourg.
General information
Firm type
Private Equity
Year founded
2023
Location
Region
Europe
Country
France
City
Paris
Corporate office
Paris, France
Principals
Laurent Van Lerberghe — Founder & Managing Partner
David Buller — Managing Partner
Pooja Majmudar — Investment Partner
Mike Zurawski — Investment Partner
Franck Lescure — Venture Partner
Gianni De Bortoli — Chief Financial Officer
Alexandre Ziad Karkour — Venture Partner
Betina Langemark — Expert Advisor
Annette Veltmar — Expert Advisor
Marie-Flore Nabor — Expert Advisor
Sector focus
Frequently asked questions
What is Keles's investment focus?
Keles is a healthcare-dedicated private equity firm investing across early-stage, venture, and growth equity opportunities. The firm targets healthcare services, digital health, and medtech companies primarily within European markets. Its multi-stage approach allows it to support companies from early development through commercial scaling.
What investment stages does Keles target?
The firm targets early-stage, venture, and growth-stage investments across the healthcare sector. This multi-stage mandate means Keles can participate in a company's first institutional round and continue supporting it through later growth equity rounds, rather than being limited to a single stage.
Where is Keles headquartered and what geographies does it cover?
Keles is headquartered in Paris, France, and focuses its investment activity on European healthcare markets. The firm's Paris location provides access to one of Europe's largest and most innovative healthcare ecosystems, including strong university-hospital networks and research institutions.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: